S J M Skinner , M S Geaney , H Lin , M Muzina , A K Anal , R B Elliott and P L J Tan
Living Cell Technologies NZ Ltd, PO Box 23 566, Hunters Corner, Manukau 2025, New Zealand
Journal of Neural Engineering Create an alert RSS this journal
S J M Skinner et al 2009 J. Neural Eng. 6 065001
In neurodegenerative disease and in acute brain injury, there is often local up-regulation of neurotrophin production close to the site of the lesion. Treatment by direct injection of neurotrophins and growth factors close to these lesion sites has repeatedly been demonstrated to improve recovery. It has therefore been proposed that transplanting viable neurotrophin-producing cells close to the trauma lesion, or site of degenerative disease, might provide a novel means for continuous delivery of these molecules directly to the site of injury or to a degenerative region. The aim of this paper is to summarize recent published information and present new experimental data that indicate that long-lasting therapeutic implants of choroid plexus (CP) neuroepithelium may be used to treat brain disease. CP produces and secretes numerous biologically active neurotrophic factors (NT). New gene microarray and proteomics data presented here indicate that many other anti-oxidant, anti-toxin and neuronal support proteins are also produced and secreted by CP cells. In the healthy brain, these circulate in the cerebrospinal fluid through the brain and spinal cord, maintaining neuronal networks and associated cells. Recent publications describe how transplanted CP cells and tissue, either free or in an immunoprotected encapsulated form, can effectively deliver therapeutic molecules when placed near the lesion or site of degenerative disease in animal models. Using simple techniques, CP neuroepithelial cell clusters in suspension culture were very durable, remaining viable for 6 months or more in vitro. The cell culture conditions had little effect on the wide range and activity of genes expressed and proteins secreted. Recently, completed experiments show that implanting CP within alginate–poly-ornithine capsules effectively protected these xenogeneic cells from the host immune system and allowed their survival for 6 months or more in the brains of rats, causing no adverse effects. Previously reported evidence demonstrated that CP cells support the survival and differentiation of neuronal cells in vitro and effectively treat acute brain injury and disease in rodents and non-human primates in vivo. The accumulated preclinical data together with the long-term survival of implanted encapsulated cells in vivo provide a sound base for the investigation of these treatments for chronic inherited and established neurodegenerative conditions.
87.80.-y Biophysical techniques (research methods)
87.19.R- Mechanical and electrical properties of tissues and organs
Issue 6 (December 2009)
Received 11 March 2009 , accepted for publication 17 June 2009
Published 23 October 2009
S J M Skinner et al 2009 J. Neural Eng. 6 065001
A K Hüttel et al 2007 J. Phys.: Condens. Matter 19 236202
A K Hüttel et al 2008 New J. Phys. 10 095003
Roberto Arias et al 2006 Metrologia 43 07005
John Wright et al 2007 Metrologia 44 07008
J E Decker et al 2007 Metrologia 44 04001
Dionisio Hernández et al 2007 Metrologia 44 01011
Otto Jusko et al 2006 Metrologia 43 04006
Kurt Weyand 2005 Metrologia 42 01006
W Sabuga et al 2005 Metrologia 42 07005